The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Category Archives: Biotech Trends in 2010

Biotech Trends in 2010: Top Three Reasons Why Biotech Companies Should Use Social Media

Tech startups use social media avidly [rabidly?], but biotech companies? Not so much.  Biotech companies should be blogging, tweeting and linking in like mad, though.  Here’s why: Your customers (pharma companies) do it.  More and more pharma companies are active in social media. Take a look at this article in the December issue of Life [...]

Biotech Trends Update — Synthetic Biology: Smallest Genome May Not Provide the Best Roadmap

One of the trends we’ll be following for 2010 is synthetic biology — efforts to create entirely novel organisms and systems from “scratch.” A fundamental question in the quest to create novel life forms is what the minimal genome is that will comprise a living organism. Scientists have been looking for, and at, existing organisms [...]

Québec’s $122 million New Biopharmaceutical Strategy Includes $30 million for Genomics, May Include SR&ED Tax Credit Financing

The Province of Québec rolled out a new “biopharmaceutical strategy” Thursday that they say aims to provide “development support for biotech and biopharmaceutical firms.” The Roll-Out: The announcement was beautifully coordinated with the relevant constituencies, as illustrated by the near-immediate chorus of support: Génome Québec said thank-you for the $30 million, we’ll get right to work. Merck Frosst [...]

Biotech Trends in 2010: Crowdsourced Edition

We’ve been running with a number of trends since the blog started early in 2009, and though many of them will continue to be critical stories in 2010, I’ve been turning my thoughts lately to possible additions for next year: Synthetic biology (this article at the Economist got a good bit of coverage); and The [...]

Follow

Get every new post delivered to your Inbox.

Join 92 other followers